IGC Pharma, Inc.

IGC · AMEX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$405$1,198$3,196$10,460
Short-Term Investments$0$0$154$0
Receivables$77$39$107$597
Inventory$1,360$1,581$2,651$3,548
Other Curr. Assets$1,054$887$358$506
Total Curr. Assets$2,896$3,705$6,466$15,111
Property Plant & Equip (Net)$3,318$3,893$8,539$9,869
Goodwill$0$0$0$0
Intangibles$1,852$1,616$1,170$917
Long-Term Investments$680$686$0$0
Tax Assets$0$0$0$0
Other NC Assets$1$2$1,003$937
Total NC Assets$5,851$6,197$10,712$11,723
Other Assets$0$0$0$0
Total Assets$8,747$9,902$17,178$26,834
Liabilities
Payables$883$773$530$981
Short-Term Debt$94$127$133$126
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,280$1,440$1,235$1,334
Total Curr. Liab.$2,257$2,340$1,898$2,441
LT Debt$144$221$348$485
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$16$20$21$16
Total NC Liab.$160$241$369$501
Other Liabilities$0$0$0$0
Cap. Leases$104$84$340$464
Total Liabilities$2,417$2,581$2,267$2,942
Equity
Pref Stock$0$0$0$0
Common Stock$130,570$124,409$118,965$116,019
Retained Earnings-$120,744-$113,665-$100,665-$89,159
AOCI-$3,496-$3,423-$3,389-$2,968
Other Equity$0$0-$0$0
Total Equity$6,330$7,321$14,911$23,892
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$8,747$9,902$17,178$26,834
Net Debt-$167-$850-$2,715-$9,849